Telesis Bio, Inc. (TBIO)

USD 0.49

(-7.55%)

Net Debt Summary of Telesis Bio, Inc.

Telesis Bio, Inc.'s latest annual net debt in 2023 was 32.63 Million USD , up 462.93% from previous year.
Telesis Bio, Inc.'s latest quarterly net debt in 2024 Q1 was 25.39 Million USD , down -22.18% from previous quarter.
Telesis Bio, Inc. reported annual net debt of -8.99 Million USD in 2022, up 86.27% from previous year.
Telesis Bio, Inc. reported annual net debt of -65.48 Million USD in 2021, down -1174.75% from previous year.
Telesis Bio, Inc. reported quarterly net debt of 25.39 Million USD for 2024 Q1, down -22.18% from previous quarter.
Telesis Bio, Inc. reported quarterly net debt of 18.35 Million USD for 2023 Q1, up 304.17% from previous quarter.

Annual Net Debt Chart of Telesis Bio, Inc. (2023 - 2016)

Historical Annual Net Debt of Telesis Bio, Inc. (2023 - 2016)

Year	Net Debt	Net Debt Growth
2023	32.63 Million USD	462.93%
2022	-8.99 Million USD	86.27%
2021	-65.48 Million USD	-1174.75%
2020	-5.13 Million USD	78.93%
2019	-24.37 Million USD	55.84%
2018	-55.19 Million USD	-14.86%
2017	-48.05 Million USD	16.75%
2016	-57.72 Million USD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	29.05 Million USD	14.42%
2024 Q1	25.39 Million USD	-22.18%
2023 Q1	18.35 Million USD	304.17%
2023 Q4	32.63 Million USD	0.35%
2023 Q2	2.65 Million USD	-85.54%
2023 FY	32.63 Million USD	462.93%
2023 Q3	32.52 Million USD	1124.9%
2022 Q3	-3.36 Million USD	38.64%
2022 Q4	-8.99 Million USD	-167.3%
2022 FY	-8.99 Million USD	86.27%
2022 Q1	-14.31 Million USD	78.15%
2022 Q2	-5.48 Million USD	61.69%
2021 Q3	-94.2 Million USD	11.15%
2021 Q1	-15 Thousand USD	99.71%
2021 FY	-65.48 Million USD	-1174.75%
2021 Q4	-65.48 Million USD	30.48%
2021 Q2	-106.02 Million USD	-706753.33%
2020 Q2	-259.82 Million USD	-723.85%
2020 Q4	-5.13 Million USD	99.16%
2020 Q3	-608.62 Million USD	-134.24%
2020 Q1	41.64 Million USD	157.87%
2020 FY	-5.13 Million USD	78.93%
2019 Q3	-86.21 Million USD	-38.86%
2019 Q1	-49.51 Million USD	10.3%
2019 FY	-24.37 Million USD	55.84%
2019 Q4	-71.96 Million USD	16.52%
2019 Q2	-62.08 Million USD	-25.38%
2018 Q1	-30.79 Million USD	35.91%
2018 FY	-55.19 Million USD	-14.86%
2018 Q4	-55.19 Million USD	-42.03%
2018 Q3	-38.86 Million USD	-135.61%
2018 Q2	-16.49 Million USD	46.44%
2017 FY	-48.05 Million USD	16.75%
2017 Q4	-48.05 Million USD	0.0%
2016 FY	-57.72 Million USD	0.0%

Peer Net Debt Comparison of Telesis Bio, Inc.

Name	Net Debt	Net Debt Difference
Acutus Medical, Inc.	12.27 Million USD	-165.779%
Biotricity, Inc.	23.09 Million USD	-41.322%
Cell MedX Corp.	244.05 Thousand USD	-13272.205%
Dynatronics Corporation	6.2 Million USD	-426.029%
Nemaura Medical Inc.	9.92 Million USD	-228.816%
PetVivo Holdings, Inc.	1.27 Million USD	-2454.325%
RetinalGenix Technologies Inc.	506.53 Thousand USD	-6342.805%
Sonendo, Inc.	26.34 Million USD	-23.89%
Talis Biomedical Corporation	-57.06 Million USD	157.19%
Viveve Medical, Inc.	-13.81 Million USD	336.263%